HBI chats with Kalle Conneryd-Lundgren, the new chief clinical operations officer at Stockholm-based digital health player Kry, to find out about his plans for the group and the market in general.
Ramsay Santé, the European branch of multinational hospital giant Ramsay Healthcare, has sealed the deal for its acquisition of listed Swedish specialty care provider GHP Specialty Care, having obtained 96.6% of its shares before the closing of the initial acceptance period on Friday, April 22.
Multiple sources say US-based buyout specialist KKR is close to closing a deal to buy Spain-based global fertility player IVI-RMA, the largest group in the sector by revenue.
Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?
Sweden has a new centre left Social Democratic government, headed by Magdalena Andersson, Sweden’s first female prime minister. What does this mean for the country’s private healthcare sector?
Ramsay Santé, the European branch of multinational hospital giant Ramsay Healthcare, has made a bid for listed Swedish specialty care provider GHP Specialty Care.
Alzheimer’s is one of the world’s most expensive diseases, costing around $1 trillion per year globally, research estimates. As cases are forecast to triple by 2050, this figure is only going to increase. To make matters worse, new research suggests that the per-person cost of treatment is also growing.
Pan-Nordic care group Attendo achieved modest revenue growth in 2021, whilst its occupancy level almost recovered to pre-pandemic levels. But it made a slight loss after taxes and its share price at SEK30.17 is down 70% from the 2017 peak.
Terveystalo, one of Finland’s two for-profit healthcare giants, saw strong growth in 2021, helped by its recent move into Sweden and a Covid boost. We speak to Terveystalo’s head of investor relations and two analysts, to analyse growth drivers.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy